FOLH1 and neoplasm: So far, PSMA PET studies addressing patient selection, prognosis, or treatment response for 177Lu-PSMA predominately focused on the use of SUV-based analyses related to PET Response Criteria in Solid Tumors (PERCIST) as well as total tumor volumes (TTV) (9–12).